|
|
PHARMA COMPLIANCE WEBINAR: MEDICAL AFFAIRS COMPLIANCE - LESSONS LEARNED AND BEST PRACTICES
Tuesday, June 7, 2016
1:00 pm - 2:30 pm (Eastern)
12:00 pm - 1:30 pm (Central)
11:00 am - 12:30 pm (Mountain)
10:00 am - 11:30 am (Pacific)
|
|
WEBINAR FACULTY
|
Brian J. Conner
Director, Huron Consulting Group, Former Sr. Director, Asst. Compliance Officer, Global Compliance, Shire Pharmaceuticals, Atlanta, GA |
Kevin L. Espinoza, MBA
Global Vice President, Ethics & Compliance, BTG International, Former R&D Compliance Officer, Forest Laboratories (now Allergan), Durham, NC
|
Kevin Ryan, JD, MS
Senior Director, Compliance: New Products, Novo Nordisk, New York, NY |
Brian A. Bohnenkamp, MHA, JD
Partner, King and Spalding LLP, Washington, DC (Moderator)
|
|
|
|
WEBINAR AGENDA
|
The Audioconference agenda is set forth in Eastern Daylight Time below:
|
|
1:00 pm |
Welcome, Introduction and Overview of Legal Framework and Landscape
Brian A. Bohnenkamp, MHA, JD
Partner, King and Spalding LLP, Washington, DC (Moderator)
|
|
1:20 pm |
Strategic Planning and the Interface between Medical Affairs and Marketing
Brian J. Conner
Director, Huron Consulting Group, Former Sr. Director, Asst. Compliance Officer, Global Compliance, Shire Pharmaceuticals Atlanta, GA
|
|
1:40 pm |
Customer-Facing Medical Affairs Roles: Medical Affairs Interactions with HCPs and Managed Markets Accounts
Kevin Ryan, JD, MS
Senior Director, Compliance: New Products, Novo Nordisk New York, NY
|
|
2:00 pm |
Medical Affairs: Operations and Measurement
Kevin L. Espinoza, MBA
Global Vice President, Ethics & Compliance, BTG International Former R&D Compliance Officer, Forest Laboratories (now Allergan) Durham, NC
|
|
2:20 pm |
Q&A
|
|
2:30 pm |
Webinar Adjournment
|
|
|
|
SPECIAL PCF REGISTRATION DISCOUNT
|
|
Click here for Special Pharmaceutical Compliance Association Member Registration Discount.
|
|
|
|
MEDIA PARTNERS:
|
|
|
CONTINUING EDUCATION CREDITS:
|
Compliance Professionals: Approved for 1.8 Compliance Certification Board CCB credits.
Click here for more information.
|
|
|
|
